TP53 and glioblastoma: Gain-of-function mutations of TP53 promote inflammation in GBM through upregulation of CCL2 and TNF-α expression via NFκB signaling, which consequently lead to increased infiltration of microglia and monocyte-derived immune cells in the TIME (148).